Vital Statistics
| Class |
Ticker |
CUSIP |
Fund Number |
| Investor |
UEPIX |
743185-811 |
002 |
| Service |
UEPSX |
743185-829 |
022 |
Inception Date for all share classes is
3/15/1999
NAV
as of
11/19/2009
| Class |
NAV |
% Change |
$ Change |
| Investor |
$14.02 |
-1.75% |
-$0.25 |
| Service |
$14.29 |
-1.79% |
-$0.26 |
At a GlanceThe Europe 30 ProFund provides exposure to the ProFunds Europe 30 Index.
ObjectiveSeeks daily investment results, before fees and expenses, that correspond to the daily performance of the ProFunds Europe 30 Index.
There is no guarantee that any ProFund will achieve its investment objective. Investment return and principal value will vary and shares may be worth more or less at redemption than at original purchase. See the prospectus for more information.
An investment in this ProFund entails the special risks of international investing, including currency exchange fluctuation, government regulations, and the potential for political and economic instability.
|
ProFunds Europe 30 Index
The ProFunds Europe 30 Index, created by ProFund Advisors, is composed of the 30 companies whose principal offices are located in Europe and whose securities are traded on U.S. exchanges or on the NASDAQ as depositary receipts or ordinary shares. The component companies in the ProFunds Europe 30 Index are determined annually based upon their U.S. dollar-traded volume. Their relative weights are determined based on a modified market capitalization method. It is not possible to invest directly in an index.
Index (as of
9/30/2009)
|
|
Top 30 Index Companies
| Name |
Weight |
| HSBC Holdings plc-Spons ADR |
6.28% |
| Royal Dutch Shell plc-ADR |
5.50% |
| BHP Billiton plc-ADR |
5.30% |
| BP plc-Spons ADR |
5.18% |
| Novartis AG-ADR |
4.78% |
| Total S.A.-Spon ADR |
4.62% |
| Vodafone Group plc-Sp ADR |
4.35% |
| GlaxoSmithKline plc-Spon ADR |
3.99% |
| Sanofi-Aventis-ADR |
3.91% |
| Siemens AG-Spons ADR |
3.62% |
|
|
| Unilever N.V. -NY Shares |
3.62% |
| Credit Suisse Group-Spon ADR |
3.32% |
| Barclays plc-Spons ADR |
3.14% |
| UBS AG-Reg |
3.03% |
| AstraZeneca plc-Spons ADR |
3.01% |
| ArcelorMittal-NY Registered |
2.94% |
| SAP AG-Sponsored ADR |
2.91% |
| Deutsche Bank AG-Registered |
2.80% |
| ABB Ltd.-Spon ADR |
2.76% |
| Alcon Inc. |
2.70% |
| Rio Tinto plc-Spon ADR |
2.69% |
| Nokia Corp.-Spon ADR |
2.60% |
| DiAGeo plc-Sponsored ADR |
2.47% |
| Telefonaktiebolaget LM Ericsson-Sp ADR |
2.31% |
| Covidien plc |
2.21% |
| Transocean Ltd. |
2.19% |
| Tyco International Ltd. |
2.18% |
| Tenaris S.A.-ADR |
2.17% |
| ACE Ltd. |
2.08% |
| DryShips Inc. |
1.33% |
Total Index Companies
30
Average Index Market Capitalization
81.14 billion
|
|
Index Sector Weightings
| Industry Groups |
Weight |
| Britain |
36.42% |
| Switzerland |
23.04% |
| Germany |
9.33% |
| Netherlands |
9.12% |
| France |
8.53% |
| Luxembourg |
5.11% |
| Finland |
2.60% |
| Sweden |
2.31% |
| Ireland |
2.21% |
| Greece |
1.33% |
|
|
Fund Statistics
| Limits On Exchanges |
None |
| Minimum Investment |
Individual Investor |
$15,000 |
|
Financial Professionals |
$5,000 |
|
All data, unless otherwise noted, is as of 9/30/2009 and for Investor Class Shares only and is subject to change.
07-00291
Investing in ProFunds involves certain risks, including in all or some cases, leverage, liquidity, concentration, non-diversification, foreign investment, foreign currency, high yield, interest rate, credit, market, correlation, aggressive investment technique and repurchase agreement risks. Moreover, there is no guarantee that any ProFund will achieve its investment objective. These risks can increase volatility and decrease performance. All ProFunds permit active investment strategies which can decrease performance and increase expenses.
|
|